Top Vaccines companies in Hong Kong by Revenue

This ranking features the top 4 Vaccines companies in Hong Kong ranked by Revenue, totaling a Revenue of USD 1.10 B, for February 04, 2025.

Hong Kong

Vaccines
Revenue
#
Name
Revenue
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
0013.HK

HUTCHMED (China) Limited

1

0013.HK
USD 838.00 M
Dec. 31, 2023 USD 2.68 -1.44%

Hong Kong
2
1521.HK

Frontage Holdings Corporation

2

1521.HK
USD 259.86 M
Dec. 31, 2023 USD 0.22 -1.18%

Hong Kong
3
3681.HK

SinoMab BioScience Limited

3

3681.HK
USD 192.26 K
Dec. 31, 2023 USD 0.13 -0.02%

Hong Kong
4
RGC

Regencell Bioscience Holdings Limited

4

RGC
USD 0.00
June 30, 2024 USD 3.80 0.53%

Hong Kong
Frequently Asked Questions
  • Which Vaccines company in Hong Kong has the highest Revenue ?

    The Vaccines company in Hong Kong with the highest Revenue is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD 838.00 M.

  • Which Vaccines company in Hong Kong has the lowest Revenue ?

    The Vaccines company in Hong Kong with the lowest Revenue is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 0.00.

SV Wall Street